Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Inventory Average for 18 consecutive years, with $824.0 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory Average rose 3.32% year-over-year to $824.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $824.0 million (up 3.32% YoY) and the FY2026 annual result came in at $824.0 million, up 3.32% from the prior year.
• Inventory Average advanced to $824.0 million in Q1 2026 per RDY's latest filing, from $797.5 million in the prior quarter.
• Over the last five years, Inventory Average for RDY reached as high as $824.0 million in Q1 2026 and fell as low as $616.0 million in Q2 2023.
• A 5-year average of $717.9 million and a median of $701.0 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average dropped 5.38% — and 2025, when it climbed 13.77%.
• Year by year, Inventory Average stood at $651.0 million in 2022, then declined by 5.38% to $616.0 million in 2023, then rose by 13.8% to $701.0 million in 2024, then advanced by 13.77% to $797.5 million in 2025, then increased by 3.32% to $824.0 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $824.0 million, $797.5 million, and $701.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.